New combination of immunotherapy drugs is safe, shrinks tumors in metastatic melanoma patients
Monday, April 20, 2015 - 11:00
in Health & Medicine
Researchers have extended the reach of the immune system in the fight against metastatic melanoma, this time by combining the checkpoint inhibitor tremelimumab with an anti-CD40 monoclonal antibody drug.